US 7256294
Crystalline form of a benzimidazole-carboxamide medicinal compound
granted A61PA61P1/00A61P1/10
Quick answer
US patent 7256294 (Crystalline form of a benzimidazole-carboxamide medicinal compound) held by Theravance, Inc. expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/00, A61P1/10, A61P1/14